Clinical Trial Equipment & Ancillary Solutions Market by Product, Type, Phase, End-Use, Indication

Description

List of Tables

The Global Clinical Trial Equipment & Ancillary Solutions Market is forecasted to grow significantly, with a projected USD 4,218.74 million in 2023 at a CAGR of 8.78% and expected to reach a staggering USD 7,620.50 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Clinical Trial Equipment & Ancillary Solutions Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Clinical Trial Equipment & Ancillary Solutions Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Equipment, Services, and Systems. The Equipment is further studied across Imaging & Diagnostic Equipment and Laboratory Equipment. The Services is further studied across Ancillary Sourcing Services, Data Management & Analysis Services, Maintenance & Calibration Services, Regulatory & Compliance Services, Site Monitoring & Support Services, and Training & Consulting Services. The Ancillary Sourcing Services is further studied across Equipment Leasing & Rental Services, Procurement, and Supply & Logistics. The Systems is further studied across Clinical Trial Management Systems, Electronic Data Capture Systems, and Randomization & Trial Supply Management. The Equipment commanded largest market share of 48.80% in 2022, followed by Services.

Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules. The Medical Devices commanded largest market share of 52.20% in 2022, followed by Biologic Drugs.

Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV. The Phase I commanded largest market share of 32.09% in 2022, followed by Phase III.

Based on End-Use, market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Medical Device Companies. The Biotechnology & Pharmaceutical Companies commanded largest market share of 36.54% in 2022, followed by Contract Research Organizations.

Based on Indication, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Digestive Disorders, Immunology, Infectious Diseases, Metabolic Disorders, and Oncology. The Immunology commanded largest market share of 18.54% in 2022, followed by Oncology.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.35% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Clinical Trial Equipment & Ancillary Solutions Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trial Equipment & Ancillary Solutions Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Equipment & Ancillary Solutions Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Equipment & Ancillary Solutions Market?

4. What is the competitive strategic window for opportunities in the Global Clinical Trial Equipment & Ancillary Solutions Market?

5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Equipment & Ancillary Solutions Market?

6. What is the market share of the leading vendors in the Global Clinical Trial Equipment & Ancillary Solutions Market?

7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Equipment & Ancillary Solutions Market?

Product Code: MRR-8C74ADFC1267

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Clinical Trial Equipment & Ancillary Solutions Market, by Product, 2022 vs 2030
4.3. Clinical Trial Equipment & Ancillary Solutions Market, by Type, 2022 vs 2030
4.4. Clinical Trial Equipment & Ancillary Solutions Market, by Phase, 2022 vs 2030
4.5. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use, 2022 vs 2030
4.6. Clinical Trial Equipment & Ancillary Solutions Market, by Indication, 2022 vs 2030
4.7. Clinical Trial Equipment & Ancillary Solutions Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Need to determine the safe and effective use of new drugs and medical device
  - 5.1.1.2. Outsourcing of clinical trial activity across the globe
  - 5.1.1.3. Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
- 5.1.2. Restraints
  - 5.1.2.1. Data security risks associated with cloud-based clinical trial solutions
- 5.1.3. Opportunities
  - 5.1.3.1. Government initiatives and support for drug development and clinical trials
  - 5.1.3.2. Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
- 5.1.4. Challenges
  - 5.1.4.1. Complexities in procedures of cross border logistics for clinical trials
5.2. Market Trends
- 5.2.1. Augmenting clinical trials and satisfactory regulatory scenario enlarge the market growth in America
- 5.2.2. Increasing number of clinical trials and the growing availability of clinical trial equipment & ancillary solutions in the Asia-Pacific region
- 5.2.3. Advancing clinical trial and drug development infrastructure with encouraging government initiatives in the EMEA region
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Clinical Trial Equipment & Ancillary Solutions Market, by Product

6.1. Introduction
6.2. Equipment
- 6.2.1. Imaging & Diagnostic Equipment
- 6.2.2. Laboratory Equipment
6.3. Services
- 6.3.1. Ancillary Sourcing Services
  - 6.3.1.1. Equipment Leasing & Rental Services
  - 6.3.1.2. Procurement
  - 6.3.1.3. Supply & Logistics
- 6.3.2. Data Management & Analysis Services
- 6.3.3. Maintenance & Calibration Services
- 6.3.4. Regulatory & Compliance Services
- 6.3.5. Site Monitoring & Support Services
- 6.3.6. Training & Consulting Services
6.4. Systems
- 6.4.1. Clinical Trial Management Systems
- 6.4.2. Electronic Data Capture Systems
- 6.4.3. Randomization & Trial Supply Management

7. Clinical Trial Equipment & Ancillary Solutions Market, by Type

7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small Molecules

8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

8.1. Introduction
8.2. Phase I
8.3. Phase II
8.4. Phase III
8.5. Phase IV

9. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology & Pharmaceutical Companies
9.4. Contract Research Organizations
9.5. Medical Device Companies

10. Clinical Trial Equipment & Ancillary Solutions Market, by Indication

10.1. Introduction
10.2. Blood Disorders
10.3. Cardiovascular Diseases
10.4. CNS & Mental Disorders
10.5. Digestive Disorders
10.6. Immunology
10.7. Infectious Diseases
10.8. Metabolic Disorders
10.9. Oncology

11. Americas Clinical Trial Equipment & Ancillary Solutions Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
- 14.3.1. Merger & Acquisition
  - 14.3.1.1. RQM+ Acquires Libra Medical
  - 14.3.1.2. Huma acquires Alcedis to expand clinical trial platform
- 14.3.2. Agreement, Collaboration, & Partnership
  - 14.3.2.1. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
  - 14.3.2.2. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
  - 14.3.2.3. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
  - 14.3.2.4. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
- 14.3.3. New Product Launch & Enhancement
  - 14.3.3.1. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
  - 14.3.3.2. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
  - 14.3.3.3. Clario Launches Cloud-Based Image Viewer for Clinical Trials
  - 14.3.3.4. Suvoda launches purpose-built software platform
  - 14.3.3.5. RQM+ Launches Clinical Trial Services
  - 14.3.3.6. Philips launches 12-lead ECG solution for decentralized clinical trials
- 14.3.4. Investment & Funding
  - 14.3.4.1. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
- 14.3.5. Award, Recognition, & Expansion
  - 14.3.5.1. ClinChoice continues expansion with CRO acquisition
  - 14.3.5.2. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China

15. List of Company Mentioned

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing